N/A
Completed N=145
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
Carcinoma, Hepatocellular · Hepatitis B
Source: ClinicalTrials.gov NCT00397540 ↗
Enrolled (actual)
145
Serious AEs
0.0%
Results posted
Mar 2010
Primary outcomePrimary: 1,3,5 Year-Disease Free Survival (or Recurrence Free Survival) — 11; 13; 25; 34 participants
Summary
The purpose of this study is to evaluate the effect of serum hepatitis B virus (HBV) DNA level on intrahepatic recurrence in locally treatable hepatocellular carcinomas (HCCs) related with HBV.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 1,3,5 Year-Disease Free Survival (or Recurrence Free Survival) |
11; 13; 25; 34; 26; 37 | — |
| SECONDARY Overall Survival |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Child-Pugh Class A or B
- Maximal tumor size less than 5 cm
- No previous history of treatment for hepatocellular carcinoma
- Recurrent hepatocellular carcinoma located more than 2 cm from the previous cancer site and is found more than 1 year's gap
Exclusion Criteria
- Hepatocellular carcinoma in portal vein
- Hepatocellular carcinoma in hepatic vein
Data sourced from ClinicalTrials.gov (NCT00397540). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.